| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |